Drug intelligence / Profile preview

citalopram + zolpidem

Development stage
Preclinical
Lead developer
Lundbeck
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

A combination of two distinct medications: citalopram, a selective serotonin reuptake inhibitor (SSRI) antidepressant used primarily for depression, and zolpidem, a non-benzodiazepine hypnotic medication used for the short-term treatment of insomnia. When used concomitantly, these medications have a moderate drug interaction that requires clinical monitoring due to potential additive sedative effects. ## Drug Interaction Profile When used together, citalopram and zolpidem have a moderate drug interaction that requires clinical attention. The primary concerns with this combination include: **Increased Sedation Risk**: Both medications can cause drowsiness, and when combined, they may lead to excessive sedation, dizziness, and impaired coordination. This combination can affect a person's ability to focus and control movements, potentially increasing the risk of falls and accidents. **CNS Depression**: The additive central nervous system depressant effects can be problematic, especially in older adults who may be more sensitive to these effects. **Metabolism Considerations**: Zolpidem is metabolized via the CYP3A4 enzyme system, while citalopram may affect various cytochrome P450 pathways, potentially altering drug metabolism.

02

Targets

SERT (Sodium-dependent serotonin transporter)BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on citalopram + zolpidem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citalopram + zolpidem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call